tag:blogger.com,1999:blog-5393996338560944889.post4176747348826481417..comments2024-03-02T02:26:00.928-05:00Comments on bleakonomy: On nature and equalitytetracontadigonhttp://www.blogger.com/profile/04604381739383227553noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-5393996338560944889.post-16444160744853548862008-12-14T10:11:00.000-05:002008-12-14T10:11:00.000-05:00Let me clarify. I am concerned only with the use ...Let me clarify. I am concerned only with the use of these drugs to boost academic performance. I have no qualms whatsoever with using them (often for their developed purpose) to slow or halt cognitive decline in people affected by Alzheimers.Danhttps://www.blogger.com/profile/11213051268392108382noreply@blogger.comtag:blogger.com,1999:blog-5393996338560944889.post-206788271568112342008-12-13T19:16:00.000-05:002008-12-13T19:16:00.000-05:00I still don't know where you'd draw the line betwe...I still don't know where you'd draw the line between what should and shouldn't be treated. <BR/><BR/>Situation a) A person of below-average "natural" intellectual ability does poorly in school, gets a low-income job, but lives to a ripe old age, with cognitive function pretty much intact to the very end.<BR/><BR/>Situation b) A person of above-average ability gets a high-income job, but develops Alzheimers late in life, and dies with a lower cognitive fuction than the person in situation a.<BR/><BR/>Aren't both of these situations natural? Wouldn't you be giving the person of situation b an unfair advantage over the person in situation a by medicating later on in life?Anonymousnoreply@blogger.com